Jiangsu Nhwa Pharmaceutical Co., Ltd.
002262
Rankning i aktier
#4620
Jiangsu Nhwa Pharmaceutical Co., LTD operates as a global pharmaceutical... Jiangsu Nhwa Pharmaceutical Co., LTD operates as a global pharmaceutical entity, focusing on the research, production, and sale of treatments for the central nervous system, along with cardiovascular and cerebrovascular ailments. Its comprehensive product line includes therapeutics for anesthesia, psychiatry, and neurological disorders. Additionally, the company is a supplier of Active Pharmaceutical Ingredients (APIs), specifically for central nervous system, anesthetic, and sedative applications, among others. The firm was established in 1978 and is based in Xuzhou, China.
Aktiekurs
$3.20
Marknadsvärde
$3.24B
Förändring (1 dag)
-2.37%
Förändring (1 år)
-11.64%
Land
CN
Handel Jiangsu Nhwa Pharmaceutical Co., Ltd. (002262)
Kategori
Healthcare
Aktiekurshistorik för Jiangsu Nhwa Pharmaceutical Co., Ltd. (002262)
Högsta slutkurs: $3.15 den 2026-10-01
Lägsta slutkurs: $0.24 den 2008-07-01
Lägsta slutkurs: $0.24 den 2008-07-01
Aktiekurshistorik för Jiangsu Nhwa Pharmaceutical Co., Ltd. från 2008 till 2026
Årlig aktiekursutveckling
| År | Prestanda |
|---|---|
| 2026 (TTM) | -7.86% |
| 2025 | 0.84% |
| 2024 | -6.47% |
| 2023 | 21.41% |
| 2022 | 29.91% |
| 2021 | -10.52% |
| 2020 | 65.99% |
| 2019 | 11.29% |
| 2018 | -34.33% |
| 2017 | 17.11% |
| 2016 | -13.62% |
| 2015 | 27.78% |
| 2014 | 21.35% |
| 2013 | 73.55% |
| 2012 | 33.53% |
| 2011 | -15.50% |
| 2010 | 63.69% |
| 2009 | 105.21% |
| 2008 | 0.00% |
Aktiekurs för liknande företag eller konkurrenter
| Företag | Aktiekurs | Förändring 1år% | Land |
|---|---|---|---|
| $171.67 | - |
DE
|
|
| $165.31 | 23.62% |
DE
|
|
| $40.45 | 43.11% |
JP
|
|
| $224.81 | 31.28% |
CH
|
|
| $18.43 | -4.03% |
IN
|
